Chesnara (LON:CSN) Announces Quarterly Earnings Results

Chesnara (LON:CSN) issued its quarterly earnings data on Tuesday. The company reported GBX 0.22 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Chesnara had a net margin of 0.04% and a return on equity of 0.25%.

Here are the key takeaways from Chesnara’s conference call:

• H1 2026 operating capital generation rose 79% to £96 million, while cash remittances increased 31% to £73 million. The performance supported a 6% increase in the interim dividend to 8.16 pence per share.
• Chesnara Life UK, acquired from HSBC in January, contributed £51 million of operating capital generation and £20 million of cash remittances in its first five months. Integration is progressing, with data migration from HSBC remaining on track for completion by the end of 2026.
• The balance sheet remains strong, with the Solvency II coverage ratio at 185%, above the 180% pro forma estimate and the company’s 140%-160% target range. This leaves capacity for further acquisitions, with management estimating roughly £130 million of immediate transaction headroom plus additional debt capacity.
• Future value increased materially, with assets under administration reaching £21 billion and the Contractual Service Margin rising from £131 million to £327 million following the Chesnara Life acquisition. Management expects 2026 new-business value to be approximately double the prior year, although M&A is expected to remain the primary growth driver.
• Sweden experienced adverse persistency and lapse trends, as outflows from higher-margin existing business exceeded inflows despite strong net client cash flows, a new Norway partnership and approximately £700 million of additional assets under administration. Dutch mortality was also adverse in Q1, though management characterized it as seasonal and said experience reverted toward its long-term average in Q2.

Chesnara Stock Up 2.0%

CSN traded up GBX 7 on Thursday, reaching GBX 356.50. The company had a trading volume of 715,386 shares, compared to its average volume of 1,059,229. Chesnara has a 1 year low of GBX 264.58 and a 1 year high of GBX 359.50. The stock has a market capitalization of £822.45 million, a PE ratio of -70.59 and a beta of 0.52. The stock has a 50-day moving average price of GBX 335.63 and a 200-day moving average price of GBX 319.80.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Royal Bank Of Canada boosted their price objective on Chesnara from GBX 360 to GBX 400 and gave the company an “outperform” rating in a report on Thursday. Berenberg Bank raised their target price on Chesnara from GBX 404 to GBX 437 and gave the company a “buy” rating in a report on Wednesday. Two analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of GBX 418.50.

Insider Buying and Selling

In related news, insider Tom Howard purchased 14,490 shares of the company’s stock in a transaction that occurred on Tuesday, August 25th. The shares were purchased at an average price of GBX 343 per share, for a total transaction of £49,700.70. Also, insider Steve Murray purchased 13,102 shares of the business’s stock in a transaction dated Tuesday, August 25th. The shares were bought at an average price of GBX 342 per share, with a total value of £44,808.84. Insiders have purchased a total of 29,045 shares of company stock worth $9,947,880 in the last 90 days. 0.87% of the stock is currently owned by company insiders.

Key Chesnara News

Here are the key news stories impacting Chesnara this week:

• Positive Sentiment: Broker optimism increased: Royal Bank of Canada raised its price target from GBX 360 to GBX 400 and assigned an “outperform” rating. Berenberg also lifted its target from GBX 404 to GBX 437 while maintaining a “buy” rating. These revisions imply further potential upside for CSN. London Stock Exchange broker ratings
• Positive Sentiment: HSBC Life acquisition is boosting growth: Recent coverage highlighted a 38% increase in assets under administration, sharply higher first-half profits and operating capital generation approaching £100 million following the deal. Cash generation reportedly rose 79%, strengthening Chesnara’s ability to pursue additional acquisitions. Chesnara’s H1 profits surge as results are boosted by HSBC deal
• Positive Sentiment: Dividend and cash-generation outlook improved: Chesnara raised its dividend after reporting stronger cash generation, which may support demand from income-focused investors and signal confidence in balance-sheet capacity. Chesnara reports stronger cash generation and raises dividend
• Positive Sentiment: Insider purchases add confidence: Tom Howard bought 14,490 shares for approximately £49,701, while Steve Murray acquired a combined 14,555 shares for roughly £49,778. Management buying near GBX 342–343 can be interpreted as a vote of confidence in CSN’s valuation and prospects. Chesnara insider buying
• Neutral Sentiment: Underlying profitability remains modest: Chesnara reported quarterly EPS of GBX 0.22, with a 0.04% net margin and 0.25% return on equity. The strong acquisition-related figures are encouraging, but investors may continue to watch whether improved cash generation translates into sustained earnings growth.

Chesnara Company Profile

Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers approximately one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.

Following a three-pillar strategy, Chesnara’s primary responsibility is the efficient administration of its customers’ life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests.